{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:10:43Z","timestamp":1791951043343,"version":"4.3.4"},"reference-count":84,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>X-linked hypophosphatemic rickets (XLH) is the commonest inherited form of rickets. It is caused by an impaired regulation of fibroblast growth factor 23 (FGF23) due to a PHEX gene mutation, which leads to reduced tubular reabsorption of phosphate and renal 1\u03b1-hydroxylase activity and increased renal 24-hydroxylase activity. Hypophosphatemia associated with renal phosphate wasting, normal serum levels of calcium, parathyroid hormone, and 25-hydroxyvitamin D represents the main biochemical sign in affected patients. Patients with XLH show rickets and osteomalacia, severe deformities of the lower limbs, bone and muscular pain, stunted growth, and reduced quality of life. However, XLH is a multisystemic disorder requiring multidisciplinary approaches in specialized subdisciplines. Severe complications may occur in patients with XLH including craniosynostosis, hearing loss, progressive bone deformities, dental and periodontal recurrent lesions, and psychosocial distress. Moreover, long-term conventional treatment with active vitamin D metabolites and oral inorganic phosphate salts may cause endocrinological complications such as secondary or tertiary hyperparathyroidism, and adverse events in kidney as hypercalciuria, nephrocalcinosis, and nephrolithiasis. However, conventional treatment does not improve phosphate metabolism and it shows poor and slow effects in improving rickets lesions and linear growth. Recently, some trials of treatment with recombinant human IgG1 monoclonal antibody that targets FGF23 (burosumab) showed significant improvement of serum phosphate concentration and renal tubular reabsorption of phosphate that were associated with a rapid healing of radiologic signs of rickets, reduced muscular and osteoarticular pain, and improved physical function, being more effective for the treatment of patients with XLH in comparison with conventional therapy. Therefore, a global management of patients with XLH is strongly recommended and patients should be seen regularly by a multidisciplinary team of experts.<\/jats:p>","DOI":"10.3389\/fendo.2021.688309","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T13:41:48Z","timestamp":1628257308000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":75,"title":["X-Linked Hypophosphatemic Rickets: Multisystemic Disorder in Children Requiring Multidisciplinary Management"],"prefix":"10.3389","volume":"12","author":[{"given":"Giampiero Igli","family":"Baroncelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005050573","article-title":"Fibroblast Growth Factor 23: Roles in Health and Disease","volume":"16","author":"Imel","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0818","article-title":"Incidence and Prevalence of Nutritional and Hereditary Rickets in Southern Denmark","volume":"160","author":"Beck-Nielsen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0515","article-title":"Hereditary Hypophosphatemia in Norway: A Retrospective Population-Based Study of Genotypes, Phenotypes, and Treatment Complications","volume":"174","author":"Rafaelsen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"17101","DOI":"10.1038\/nrdp.2017.101","article-title":"Rickets","volume":"3","author":"Carpenter","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13052-019-0654-6","article-title":"X-Linked Hypophosphatemic Rickets: An Italian Experts\u2019 Opinion Survey","volume":"45","author":"Emma","year":"2019","journal-title":"Ital J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00590-014-1496-y","article-title":"Hypophosphatemic Rickets: Etiology, Clinical Features and Treatment","volume":"25","author":"Pavone","year":"2015","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","article-title":"The Expanding Family of Hypophosphatemic Syndromes","volume":"30","author":"Carpenter","year":"2012","journal-title":"J Bone Miner Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical Practice Recommendations for the Diagnosis and Management of X-Linked Hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.119","article-title":"Dental Abnormalities in Patients With Familial Hypophosphatemic Vitamin D-Resistant Rickets: Prevention by Early Treatment With 1-Hydroxyvitamin D","volume":"142","author":"Chaussain-Miller","year":"2003","journal-title":"J Pediatr"},{"key":"B10","article-title":"Prevalence and Pathogenesis of Dental and Periodontal Lesions in Children With X-linked Hypophosphatemic Rickets","volume":"7","author":"Baroncelli","year":"2006","journal-title":"Eur J Paediatr Dent"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01136-8","article-title":"Pulp Chamber Features, Prevalence of Abscesses, Disease Severity, and PHEX Mutation in X-Linked Hypophosphatemic Rickets","volume":"39","author":"Baroncelli","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.05.040","article-title":"Clinical and Molecular Heterogeneity in a Large Series of Patients With Hypophosphatemic Rickets","volume":"79","author":"Capelli","year":"2015","journal-title":"Bone"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.01.021","article-title":"Clinical and Genetic Analysis in a Large Chinese Cohort of Patients With X-Linked Hypophosphatemia","volume":"121","author":"Zhang","year":"2019","journal-title":"Bone"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of Adult Patients With X-Linked Hypophosphatemia Caused by PHEX Gene Mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/jendso\/bvaa151","article-title":"X-Linked Hypophosphatemia: A New Era in Management","volume":"4","author":"Dahir","year":"2020","journal-title":"J Endocr Soc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz203","article-title":"Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia: A United Kingdom Real-World Data Analysis","volume":"105","author":"Hawley","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/46.3.132","article-title":"Radiographic Scoring Method for the Assessment of the Severity of Nutritional Rickets","volume":"46","author":"Thacher","year":"2000","journal-title":"J Trop Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bone.2019.02.010","article-title":"Rickets Severity Predicts Clinical Outcomes in Children With X-Linked Hypophosphatemia: Utility of the Radiographic Rickets Severity Score","volume":"122","author":"Thacher","year":"2019","journal-title":"Bone"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.115964","article-title":"Validation of the Radiographic Global Impression of Change (Rgi-C) Score to Assess Healing of Rickets in Pediatric X-Linked Hypophosphatemia (XLH)","volume":"148","author":"Lin","year":"2021","journal-title":"Bone"},{"key":"B20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12325-019-01183-2","article-title":"Usefulness of X-Rays in the Differential Diagnosis of Hypophosphataemic Rickets","volume":"37","author":"Martel-Villagr\u00e1n","year":"2020","journal-title":"Adv Ther"},{"key":"B21","article-title":"Genetic Advances, Biochemical and Clinical Features and Critical Approach to Treatment of Patients With X-Linked Hypophosphatemic Rickets","volume":"1","author":"Baroncelli","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.340","article-title":"A Clinician\u2019s Guide to X-Linked Hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic Management of Hypophosphatemic Rickets From Infancy to Adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"B24","doi-asserted-by":"publisher","first-page":"153892","DOI":"10.1016\/j.metabol.2019.03.009","article-title":"Diagnosis, Treatment-Monitoring and Follow-Up of Children and Adolescents With X-Linked Hypophosphatemia (XLH)","author":"Rothenbuhler","year":"2020","journal-title":"Metabolism"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030036","article-title":"Early Treatment Improves Growth and Biochemical and Radiographic Outcome in X-Linked Ypophosphatemic Rickets","volume":"88","author":"Makitie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/clinem\/dgaa495","article-title":"Growth Curves for Children With X-Linked Hypophosphatemia","volume":"105","author":"Mao","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/BF01959355","article-title":"The Pattern of Growth and Growth Retardation of Patients With Hypophosphataemic Vitamin D-Resistant Rickets: A Longitudinal Study","volume":"151","author":"Steendijk","year":"1992","journal-title":"Eur J Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2553","article-title":"Vitamin D Receptor Genotype in Hypophosphatemic Rickets as a Predictor of Growth and Response to Treatment","volume":"93","author":"Jehan","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab Therapy in Children With X-Linked Hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Efficacy and Safety of Burosumab in Children Aged 1-4 Years With X-Linked Hypophosphataemia: A Multicentre, Open-Label, Phase 2 Trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Burosumab Versus Conventional Therapy in Children With X-Linked Hypophosphataemia: A Randomised, Active-Controlled, Open-Label, Phase 3 Trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0399","article-title":"Three-Year Growth Hormone Treatment in Short Children With X-Linked Hypophosphatemic Rickets: Effects on Linear Growth and Body Disproportion","volume":"96","author":"Zivi\u010dnjak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-017-9408-1","article-title":"X-Linked Hypophosphatemia and Growth","volume":"18","author":"Fuente","year":"2017","journal-title":"Rev Endocr Metab Disord"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.03.009","article-title":"Dentin Structure in Familial Hypophosphatemic Rickets: Benefits of Vitamin D and Phosphate Treatment","volume":"13","author":"Chaussain-Miller","year":"2007","journal-title":"Oral Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional Therapy in Adults With X-Linked Hypophosphatemia: Effects on Enthesopathy and Dental Disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322010001000017","article-title":"Dental Abnormalities and Oral Health in Patients With Hypophosphatemic Rickets","volume":"65","author":"Souza","year":"2010","journal-title":"Clinics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050340","article-title":"X-Linked Hypophosphatemia: Effects of Treatment With Recombinant Human Growth Hormone","volume":"11","author":"Reusz","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1542\/peds.100.5.879","article-title":"The Effect of Recombinant Human Growth Hormone in Children With X-Linked Hypophosphatemia","volume":"100","author":"Seikaly","year":"1997","journal-title":"Pediatrics"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.108955","article-title":"Effect of Growth Hormone Treatment on Final Height, Phosphate Metabolism, and Bone Mineral Density in Children With X-Linked Hypophosphatemic Rickets","volume":"138","author":"Baroncelli","year":"2001","journal-title":"J Pediatr"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.6.e593","article-title":"Effects of Growth Hormone Treatment on Body Proportions and Final Height Among Small Children With X-Linked Hypophosphatemic Rickets","volume":"113","author":"Haffner","year":"2004","journal-title":"Pediatrics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004447.pub2","article-title":"Recombinant Growth Hormone Therapy for X-Linked Hypophosphatemia in Children","volume":"1","author":"Huiming","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000113021","article-title":"Metabolic Control and Growth During Exclusive Growth Hormone Treatment in X-Linked Hypophosphatemic Rickets","volume":"69","author":"Makitie","year":"2008","journal-title":"Horm Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ghir.2017.08.001","article-title":"Two-Year Recombinant Human Growth Hormone (rhGH) Treatment Is More Effective in Pre-Pubertal Compared to Pubertal Short Children With X-Linked Hypophosphatemic Rickets (XLHR)","volume":"36","author":"Rothenbuhler","year":"2017","journal-title":"Growth Horm IGF Res"},{"key":"B44","first-page":"2","article-title":"Linear Growth During Growth Hormone Treatment in X-Linked Hypophosphatemic Rickets: Report of Two Patients","author":"Baroncelli","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-017-3820-3","article-title":"Effects of Growth Hormone Treatment on Adult Height in Severely Short Children With X-Linked Hypophosphatemic Rickets","volume":"33","author":"Meyerhoff","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype Presentation of Hypophosphatemic Rickets in Adults","volume":"87","author":"Beck-Nielsen","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02465-x","article-title":"Exploring the Burden of X-Linked Hypophosphatemia: A European Multi-Country Qualitative Study","volume":"29","author":"Lo","year":"2020","journal-title":"Qual Life Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/01.bpo.0000218531.66856.b7","article-title":"Hypophosphatemic Rickets: The Role of Hemiepiphysiodesis","volume":"26","author":"Novais","year":"2006","journal-title":"J Pediatr Orthop"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/BPO.0b013e3181841fda","article-title":"Guided Growth for Pathological Physes: Radiographic Improvement During Realignment","volume":"28","author":"Stevens","year":"2008","journal-title":"J Pediatr Orthop"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-201009000-00004","article-title":"Guided Growth for the Correction of Pediatric Lower Limb Angular Deformity","volume":"18","author":"Saran","year":"2010","journal-title":"J Am Acad Orthop Surg"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1302\/1863-2548.12.170050","article-title":"Guided Growth: Preliminary Results of a Multinational Study of 967 Physes in 537 Patients","volume":"12","author":"Danino","year":"2018","journal-title":"J Child Orthop"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-021-00828-8","article-title":"Epiphysiodesis for the Treatment of Tall Stature and Leg Length Discrepancy","volume":"171","author":"Willegger","year":"2021","journal-title":"Wien Med Wochenschr"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.5435\/JAAOSGlobal-D-19-00009","article-title":"Growth Modulation for Knee Coronal Plane Deformities in Children With Nutritional Rickets: A Prospective Series With Treatment Algorithm","volume":"4","author":"EL-Sobky","year":"2020","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/17453670610046073","article-title":"Deformity Correction by External Fixation and\/or Intramedullary Nailing in Hypophosphatemic Rickets","volume":"77","author":"Song","year":"2006","journal-title":"Acta Orthop"},{"key":"B55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1302\/1863-2548.11.170003","article-title":"The Orthopaedic Management of Lower Limb Deformity in Hypophosphataemic Rickets","volume":"11","author":"Horn","year":"2017","journal-title":"J Child Orthop"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10354-019-00732-2","article-title":"Multidisciplinary Patient Care in X-Linked Hypophosphatemic Rickets: One Challenge, Many Perspectives","volume":"170","author":"Raimann","year":"2020","journal-title":"Wien Med Wochenschr"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1443-y","article-title":"The Enigma of Hyperparathyroidism in Hypophosphatemic Rickets","volume":"19","author":"Schmitt","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.06.025","article-title":"Hyperparathyroidism and Parathyroidectomy in X-Linked Hypophosphatemia Patients","volume":"127","author":"DeLacey","year":"2019","journal-title":"Bone"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01685.x","article-title":"Prolonged High-Dose Phosphate Treatment: A Risk Factor for Tertiary Hyperparathyroidism in X-Linked Hypophosphatemic Rickets","volume":"58","author":"Makitie","year":"2003","journal-title":"Clin Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.6.1464657","article-title":"Tertiary Hyperparathyroidism During High Phosphate Therapy of Familial Hypophosphatemic Rickets","volume":"75","author":"Rivkees","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0481","article-title":"Increased Prevalence of Overweight and Obesity in Children With X-Linked Hypophosphatemia","volume":"9","author":"Zhukouskaya","year":"2020","journal-title":"Endocr Connect"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00338","article-title":"Nephrocalcinosis and Nephrolithiasis in X-Linked Hypophosphatemic Rickets: Diagnostic Imaging and Risk Factors","volume":"3","author":"Colares Neto","year":"2019","journal-title":"J Endocr Soc"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-007-0503-4","article-title":"Sagittal Synostosis in X-Linked Hypophosphatemic Rickets and Related Diseases","volume":"37","author":"Currarino","year":"2007","journal-title":"Pediatr Radiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3171\/2015.10.PEDS15273","article-title":"Hypophosphatemic Rickets and Craniosynostosis: A Multicenter Case Series","volume":"17","author":"Vega","year":"2016","journal-title":"J Neurosurg Pediatr"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-015-2934-9","article-title":"X-Linked Hypophosphatemic Rickets and Sagittal Craniosynostosis: Three Patients Requiring Operative Cranial Expansion: Case Series and Literature Review","volume":"32","author":"Jaszczuk","year":"2016","journal-title":"Childs Nerv Syst"},{"key":"B66","doi-asserted-by":"publisher","first-page":"e20172522","DOI":"10.1542\/peds.2017-2522","article-title":"Craniosynostosis as the Presenting Feature of X-Linked Hypophosphatemic Rickets","volume":"141","author":"Vakharia","year":"2018","journal-title":"Pediatrics"},{"key":"B67","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/s0022-3476(64)80192-x","article-title":"Craniosynostosis in the Rachitic Spectrum","volume":"64","author":"Reilly","year":"1964","journal-title":"J Pediatr"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3614","article-title":"High Incidence of Cranial Synostosis and Chiari 1 Malformation in Children With X-Linked Hypophosphatemic Rickets (XLHR)","volume":"34","author":"Rothenbuhler","year":"2019","journal-title":"J Bone Miner Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.195.3.7754003","article-title":"Chiari I Malformation: Association With Hypophosphatemic Rickets and MR Imaging Appearance","volume":"195","author":"Caldemeyer","year":"1995","journal-title":"Radiology"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-211961","article-title":"Chiari Malformation, Syringomyelia and Bulbar Palsy in X-Linked Hypophosphataemia","volume":"2015","author":"Watts","year":"2015","journal-title":"BMJ Case Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/j.1601-0825.2006.01326.x","article-title":"Dentin Structure in Familial Hypophosphatemic Rickets: Benefits of Vitamin D and Phosphate Treatment","volume":"13","author":"Chaussain-Miller","year":"2007","journal-title":"Oral Dis"},{"key":"B72","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00223-006-0182-4","article-title":"Dentin Alteration of Deciduous Teeth in Human Hypophosphatemic Rickets","volume":"79","author":"Boukpessi","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/sca.21141","article-title":"Piana G. X-Linked Hypophosphatemic Rickets: Enamel Abnormalities and Oral Clinical Findings","volume":"36","author":"Cremonesi","year":"2014","journal-title":"Scanning"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2009.090129","article-title":"Aberrant Cementum Phenotype Associated With the Hypophosphatemic Hyp Mouse","volume":"80","author":"Fong","year":"2009","journal-title":"J Periodontol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2017.07.026","article-title":"Tissue-Specific Mineralization Defects in the Periodontium of the Hyp Mouse Model of X-Linked Hypophosphatemia","volume":"103","author":"Coyac","year":"2017","journal-title":"Bone"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00365","article-title":"The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-2-230","article-title":"Impaired Hearing in X-Linked Hypophosphataemic (Vitamin-D-Resistant) Osteomalacia","volume":"100","author":"Davies","year":"1984","journal-title":"Ann Int Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3109\/00016488509108581","article-title":"Electrocochleographic Changes in the Hearing Loss Associated With X-Linked Hypophosphataemic Osteomalacia","volume":"100","author":"O\u2019Malley","year":"1985","journal-title":"Acta Otolaryngol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-004-1504-z","article-title":"Hearing Impairment in Familial X-Linked Hypophosphatemic Rickets","volume":"163","author":"Fishman","year":"2004","journal-title":"Eur J Pediatr"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/s0009-9260(88)80224-1","article-title":"The Petrous Temporal Bone and Deafness in X-Linked Hypophosphataemic Osteomalacia","volume":"39","author":"O\u2019Malley","year":"1988","journal-title":"Clin Radiol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.amjoto.2016.09.014","article-title":"Treatment of Ear and Bone Disease in the Phex Mouse Mutant With Dietary Supplementation","volume":"38","author":"Wick","year":"2017","journal-title":"Am J Otolaryngol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-020-00797-x","article-title":"Patient-Reported Outcomes From a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children With X-Linked Hypophosphatemia","volume":"108","author":"Padidela","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired Quality of Life in Adults With X-Linked Hypophosphatemia and Skeletal Symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00198-020-05548-0","article-title":"Burden of Disease Associated With X-Linked Hypophosphataemia in Adults: A Systematic Literature Review","volume":"32","author":"Seefried","year":"2021","journal-title":"Osteop Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.688309\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T13:41:54Z","timestamp":1628257314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.688309\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":84,"alternative-id":["10.3389\/fendo.2021.688309"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.688309","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"article-number":"688309"}}